Regulus Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Regulus Therapeutics is a biotechnology research company focused on discovering and developing medicines that target microRNAs. It is based in San Diego, California, and employs 11 to 50 people. The company leverages oligonucleotide drug discovery and development expertise to pursue a microRNA therapeutics pipeline, complemented by a microMarkers biomarkers platform and an extensive intellectual property portfolio. Regulus is led by an experienced management team and supported by a scientific advisory board that includes leading researchers in the microRNA field. In 2025, reports indicate that Novartis Pharmaceuticals Corporation announced plans to acquire Regulus Therapeutics for up to $1.7 billion. Regulus Therapeutics is listed on the Nasdaq stock exchange under the ticker RGLS.

Sign up for free to view info

Company overview Employee directory